The primary purpose of otoacoustic emission (OAE) tests is to determine cochlear status, specifically hair cell function. This information can be used to (1) screen hearing (particularly in neonates, infants, or individuals with developmental disabilities), (2) partially estimate hearing sensitivity within a limited range, (3) differentiate between the sensory and neural components of sensorineural hearing loss, and (4) test for functional (feigned) hearing loss. The information can be obtained from patients who are sleeping or even comatose because no behavioral response is required.
The normal cochlea does not just receive sound; it also produces low-intensity sounds called OAEs. These sounds are produced specifically by the cochlea and, most probably, by the cochlear outer hair cells as they expand and contract. The presence of cochlear emissions was hypothesized in the 1940s on the basis of mathematical models of cochlear nonlinearity. However, OAEs could not be measured until the late 1970s, when extremely sensitive low-noise microphones needed to record these responses became available.
The four types of OEAs are as follows:
Spontaneous otoacoustic emissions (SOAEs) – Sounds emitted without an acoustic stimulus (ie, spontaneously)
Transient otoacoustic emissions (TOAEs) or transient evoked otoacoustic emissions (TEOAEs) – Sounds emitted in response to an acoustic stimuli of very short duration; usually clicks but can be tone-bursts
Sustained-frequency otoacoustic emissions (SFOAEs) – Sounds emitted in response to a continuous tone
Pure-tone (PT) audiometry measures throughout the outer ear, middle ear, cochlea, cranial nerve (CN) VIII, and central auditory system. However, OAEs measure only the peripheral auditory system, which includes the outer ear, middle ear, and cochlea. The response only emanates from the cochlea, but the outer and middle ear must be able to transmit the emitted sound back to the recording microphone. OAE testing often is used as a screening tool to determine the presence or aBSEnce of cochlear function, although analysis can be performed for individual cochlear frequency regions. OAEs cannot be used to fully describe an individual’s auditory thresholds, but they can help question or validate other threshold measures (eg, in suspected functional [feigned] hearing loss), or they can provide information about the site of the lesion.
Using current technology, most researchers and clinicians find a correlation between frequency-specific analysis of TOAEs/DPOAEs and cochlear hearing loss. However, at this juncture, the correlation cannot fully describe auditory threshold. Naturally, a correlation would not be expected for noncochlear hearing loss.
Insert a probe with a soft flexible tip in the ear canal to obtain a seal. Use different probes for neonates and adults; the probes are calibrated differently because of the significant difference in ear canal volume. The smaller ear canal results in a higher effective sound pressure level (SPL), thus a different probe is used to correct for the difference.
Multiple responses are averaged. All OAEs are analyzed relative to the noise floor; therefore, reduction of physiologic and acoustic ambient noise is critical for good recordings. Because no behavioral response is required, OAEs can be obtained even from patients who are comatose. For a quiet and cooperative patient, recordings usually require less a few minutes per ear. For an uncooperative or noisy patient, recordings may take significantly longer or may be impossible to obtain on a given visit.
For all OAEs, an optimal probe fit is critical. Complete information on recording and interpreting OAEs is beyond the scope of this article; for discussions that are more comprehensive, please see the bibliography.
Clicks are the most commonly used stimuli, although tone-burst stimuli may be used. Most commonly, 80- to 85-dB SPL stimuli are used clinically. The stimulation rate is less than 60 stimuli per second. TOAEs are generally recorded in the time domain over approximately 20 milliseconds. Alternating responses are stored in alternating computer memory banks, A and B. Data that correlate between the 2 memory banks are considered a response. Data that do not correlate are considered noise. When present, TOAEs generally occur at frequencies of 500-4000 Hz. Data in the time domain then are converted to the frequency domain, usually in octave band analysis. 
Stimuli consist of 2 pure tones at 2 frequencies (ie, f1, f2 [f2>f1]) and 2 intensity levels (ie, L1, L2). The relationship between L1-L2 and f1-f2 dictates the frequency response. An f1/f2 ratio yields the greatest DPOAEs at 1.2 for low and high frequencies and at 1.3 for medium frequencies. To yield an optimal response, set intensities so that L1 equals or exceeds L2. Lowering the absolute intensity of the stimulus renders the DPOAEs more sensitive to abnormality. A setting of 65/55 dB SPL L1/L2 is frequently used. Responses are usually most robust and recorded at the emitted frequency of 2 f1–f2; however, they generally are charted according to f2 because that region approximates the cochlear frequency region generating the response. 
Prerequisities include the following:
Unobstructed outer ear canal
Seal of the ear canal with the probe
Optimal positioning of the probe
Functioning cochlear outer hair cells
In general, SOAEs occur in only 40-50% of individuals who have normal hearing. For these adults, the range is about 30-60%; in neonates with normal hearing, the range is approximately 25-80%. SOAEs generally are not found in individuals with hearing thresholds worse than 30 dB HL. Therefore, the presence of SOAEs usually is considered a sign of cochlear health, but the aBSEnce of SOAEs is not necessarily a sign of abnormality.
SOAEs typically are bilateral rather than unilateral. If unilateral, they are more likely to be present in the right rather than in the left ear. SOAEs occur more often in females than in males (across all ages).
Usually, SOAEs are not associated with tinnitus. Because tinnitus often occurs in conjunction with cochlear abnormality, SOAEs usually are aBSEnt. SOAEs are seldom used clinically to screen hearing. The aBSEnce of SOAEs does not imply abnormal auditory function, as indicated above.
High-level SOAEs may occur. These emissions can be heard by others. Objective tinnitus is usually a misnomer because the patient often cannot hear these noises. Such emissions are very uncommon but may coexist with sensory hearing loss. High-level SOAEs are more common in children than in adults.
In the clinic, TOAEs commonly are used to screen infant hearing, to validate behavioral or electrophysiologic auditory thresholds, and to assess cochlear function relative to the site of the lesion. By definition, TOAEs are recorded only in response to very short or transient stimuli. Therefore, the stimulus has limited frequency specificity, and the TOAE emanates from a relatively broad cochlear region. However, current analysis techniques allow the response to be separated into various frequency bands for analysis.
In general, the presence of a TOAE in a particular frequency band suggests that cochlear sensitivity in that region is approximately 20-40 dB HL or better, depending on the study cited. Most clinicians use the presence of a TOAE in a particular octave band to suggest that hearing sensitivity should be 30 dB HL or better, unless a functional or neural component is present.
The relative merits of TOAEs and DPOAEs are widely discussed. Essentially, DPOAEs allow greater frequency specificity and can be used to record at higher frequencies than TOAEs. Therefore, DPOAEs may be as particularly useful for early detection of cochlear damage as they are for ototoxicity and noise-induced damage. However, large-scale comparative studies of TOAEs and DPOAEs in these groups of patients currently are lacking. Reliability of DPOAEs is greatest above 1000 Hz.
For infant hearing screening, both DPOAEs and TOAEs are used. TOAEs have been used clinically for a longer period and are more established regarding association with behavioral audiometric thresholds.
Depending on the methodology employed, DPOAEs often can be recorded in individuals with mild-to-moderate hearing losses for whom TOAEs are aBSEnt; however, the accuracy of DPOAEs in estimating actual hearing sensitivity is not fully resolved (research continues in this area). DPOAEs frequently correspond to the audiometric configuration of a cochlear hearing loss, which is helpful in some patients.
A retrospective study by Wooles et al indicated that DPOAEs would not be a useful replacement for pure tone audiometry in longitudinal screening for auditory deficits related to occupational noise exposure. In an analysis of 16 brickyard workers, the study found that, although the pure tone audiometry threshold was elevated in 13 of the workers, seven of the workers had substantial DPOAEs at the frequencies associated with these thresholds. 
SFOAEs are responses recorded to a continuous tone. Because the stimulus and the emission overlap in the ear canal, the recording microphone detects both. Therefore, interpretation depends on reading a complicated series of ripples in the recording. At present, SFOAEs are not used clinically.
These include the following:
Cerumen occluding the canal or blocking a probe port
Debris and foreign objects in the outer ear canal
Vernix caseosa in neonates: This is common immediately after birth
Uncooperative patient: Usually, recordings simply are not obtained
A study by Abdala et al indicated that DPOAEs have a greater rate of decline with age than do SFOAEs, with the investigators finding evidence that age-related increases in intracochlear roughness may lead to the relative preservation of SFOAE levels. 
Abnormal middle ear pressure
Tympanic membrane – Perforation of the eardrum (PE tubes do not necessarily prevent good recordings.)
Middle ear disarticulation
Bilateral otitis media: To record OAEs, the cochlear response must be able to travel efficiently through the middle ear and tympanic membrane to the recording microphone in the ear canal. Even in the presence of normal cochlear function, OAEs generally are aBSEnt in the presence of otitis media. OAE testing is best conducted after the otitis media has cleared. If the patient cannot be tested later, when the otitis has cleared, no harm exists in attempting to record OAEs. If OAEs are present (as in a very small percentage of patients with otitis media), that information could be useful. If they are aBSEnt (as in most patients with otitis media), no conclusions about cochlear function can be drawn.
Any other cochlear pathology
See the list below:
CN VIII pathology: If CN VIII pathology also affects the cochlea (eg, vestibular schwannoma that decreases cochlear vascular supply), OAEs are affected.
Central auditory disorder
See the list below:
Tinnitus: OAEs may be abnormal in the frequency region of the tinnitus.
See the list below:
Functional hearing loss
Possibly, inner hair cell damage but normal outer hair cells (reported for animals but no human reports yet)
Auditory neuropathy: This includes central auditory nervous system dysfunction and CN VIII auditory dysfunction.
The advent of otoacoustic emissions (OAE) recordings opened a new area of auditory investigation in auditory neuropathy. Although auditory neuropathy is not a new disorder, OAEs have triggered numerous new studies. Auditory neuropathy is also more common than previously thought.  Therefore, a more complete listing is provided for this disorder.
Classic auditory neuropathy is characterized by the presence of OAEs or enlarged cochlear microphonics, abnormal auditory brainstem response (ABR) findings, and, often, aBSEnt or abnormal behavioral responses to sound. (OAEs may be aBSEnt and an auditory neuropathy still may exist if concomitant cochlear disorder is present. Also OAEs may often disappear over time in auditory neuropathy patients.)
ABR abnormalities consistent with auditory neuropathy include aBSEnce of all ABR waveforms or prolonged interpeak latencies. A large cochlear microphonic sometimes is oBSErved on the ABR recordings for these patients. The patient with auditory neuropathy may have any type of audiometric configuration, but rising or flat configurations are most common. Often, the patient’s word recognition is disproportionately poor relative to PT thresholds. listening in noise usually is very difficult. Hearing may fluctuate. Over time, it may stabilize, improve, or progress to profound hearing loss. If the etiology is known, a more accurate prognosis may frequently be given; however, the disorder can be idiopathic.
The cause of auditory neuropathy sometimes is unknown; however, the following conditions may be associated with pediatric auditory neuropathy:
Hereditary motor sensory neuropathologies (eg, Charcot-Marie-Tooth diseases with deafness)
Severe and/or pervasive developmental delay
A study by Narne et al suggested that TOAE variations can aid in understanding the pathophysiology of auditory neuropathy. In the study, of 15 persons with an auditory neuropathy spectrum disorder and 22 individuals with normal hearing, wavelet analysis in narrow-band frequency regions indicated that TOAEs in the auditory neuropathy group had a higher amplitude and slightly shorter latency than did TOAEs in the group with normal hearing, at low frequencies and midfrequencies. These differences, according to the investigators, could be ascribed to efferent system damage in auditory neuropathy. 
Because OAEs may be new to some clinicians, a brief review of the relevant anatomy and physiology is provided.
When sound is used to elicit an emission, it is transmitted through the outer ear, where the auditory stimulus is converted from an acoustic signal to a mechanical signal at the tympanic membrane and is transmitted through the middle ear ossicles; the stapes footplate moves at the oval window, causing a traveling wave in the fluid-filled cochlea. The cochlear fluid’s traveling wave moves the basilar membrane; each portion of the basilar membrane is maximally sensitive to only a limited frequency range. The arrangement is a tonotopic gradient. Regions closest to the oval window are more sensitive to high-frequency stimuli. Regions further away are most sensitive to lower-frequency stimuli. Therefore, for OAEs, the first responses returned and recorded by the probe microphone emanate from the highest-frequency cochlear regions because the travel distance is shorter. Responses from the lower-frequency regions, closer to the cochlear apex, arrive later.
When the basilar membrane moves, the hair cells are set into motion and an electromechanical response is elicited, while an afferent signal is transmitted and an efferent signal is emitted. The efferent signal is transmitted back through the auditory pathway, and the signal is measured in the outer ear canal. As described above, the responses from the high-frequency region arrive first, progressively followed by responses from lower-frequency regions.
Outer hair cells are located in the organ of Corti on the basilar membrane. These hair cells are motile; an electrochemical response elicits a motoric response. The 3 rows of outer hair cells have stereocilia arranged in a W formation. The stereocilia are linked to each other and, therefore, move as a unit. These are the outer hair cells believed to underlie OAE generation.
Petersen L, Wilson WJ, Kathard H. Towards the preferred stimulus parameters for distortion product otoacoustic emissions in adults: A preliminary study. S Afr J Commun Disord. 2018 Jul 16. 65 (1):e1-e10. [Medline].
Wooles N, Mulheran M, Bray P, Brewster M, Banerjee AR. Comparison of distortion product otoacoustic emissions and pure tone audiometry in occupational screening for auditory deficit due to noise exposure. J Laryngol Otol. 2015 Dec. 129 (12):1174-81. [Medline].
Abdala C, Ortmann AJ, Shera CA. Reflection- and Distortion-Source Otoacoustic Emissions: Evidence for Increased Irregularity in the Human Cochlea During Aging. J Assoc Res Otolaryngol. 2018 Jul 2. [Medline].
Helleman HW, Dreschler WA. Overall versus individual changes for otoacoustic emissions and audiometry in a noise-exposed cohort. Int J Audiol. 2012 May. 51(5):362-72. [Medline].
Kathleen C M Campbell, PhD is a member of the following Medical societies: American Academy of Audiology, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Speech-Language-Hearing Association, Association for Research in Otolaryngology, International Society of Audiology
Disclosure: Nothing to disclose.
Ginger Mullin, AuD Illinois EHDI Program, Illinois Department of Public Health
Disclosure: Nothing to disclose.
Disclosure: Received salary from Medscape for employment. for: Medscape.
Peter S Roland, MD Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director, Clinical Center for Auditory, Vestibular, and Facial Nerve Disorders, Chief of pediatric Otology, University of Texas Southwestern Medical Center; Chief of pediatric Otology, Children’s Medical Center of Dallas; President of Medical Staff, Parkland Memorial Hospital; Adjunct Professor of Communicative Disorders, School of Behavioral and Brain Sciences, Chief of Medical Service, Callier Center for Communicative Disorders, University of Texas School of Human Development
Peter S Roland, MD is a member of the following Medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Neurotology Society, American Otological Society, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, The Triological Society
Disclosure: Received honoraria from Alcon Labs for consulting; Received honoraria from Advanced Bionics for board membership; Received honoraria from Cochlear Corp for board membership; Received travel grants from Med El Corp for consulting.
Arlen D Meyers, MD, MBA is a member of the following Medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;Cliexa;Preacute Population Health Management;The Physicians Edge
Received income in an amount equal to or greater than $250 from: The Physicians Edge, Cliexa
Received stock from RxRevu; Received ownership interest from Cerescan for consulting; for: Rxblockchain;Bridge Health.
Ted L Tewfik, MD Professor of Otolaryngology-Head and Neck Surgery, Professor of pediatric Surgery, McGill University Faculty of Medicine; Senior Staff, Montreal Children’s Hospital, Montreal General Hospital, and Royal Victoria Hospital
Ted L Tewfik, MD is a member of the following Medical societies: American Society of Pediatric Otolaryngology, Canadian Society of Otolaryngology-Head & Neck Surgery
Disclosure: Nothing to disclose.